Mechanisms involved in extracellular matrix remodeling and arterial stiffness induced by hyaluronan accumulation

Atherosclerosis

Volumn 244, Issue , 2016, Pages 195-203

  Lorentzen, Karen Axelgaard ^a   Chai, Song ^a,b   Chen, Hui ^a,c   Danielsen, Carl Christian ^a   Simonsen, Ulf ^a   Wogensen, Lise ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c PEOPLE'S HOSPITAL OF GUANGXI ZHUANG AUTONOMOUS REGION   (China)

Author keywords

Arterial stiffness; Atherosclerosis; Diabetic angiopathy; Extracellular matrix; Hyaluronan; Inter Inhibitor; Vascular smooth muscle cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; HYALURONIC ACID; LOW DENSITY LIPOPROTEIN; OSTEOPROTEGERIN; THYMIDINE; ECM1 PROTEIN, MOUSE; IMMUNOLOGICAL ADJUVANT; RNA; SCLEROPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTERIAL STIFFNESS; ARTICLE; ATHEROSCLEROSIS; BIOMECHANICS; CELL DIFFERENTIATION; CONTROLLED STUDY; CROSS LINKING; DNA SYNTHESIS; ELECTRON MICROSCOPY; EXTRACELLULAR MATRIX; FEMALE; IMMUNOBLOTTING; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CELL MOTION; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORACIC AORTA; TRANSGENIC MOUSE; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; AORTA, THORACIC; ATHEROSCLEROSIS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION REGULATION; HYALURONIC ACID; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCLE, SMOOTH, VASCULAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; VASCULAR REMODELING; VASCULAR STIFFNESS;

EID: 84949239000     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.11.016     Document Type: Article

References (28)

1. Andresen J.L., Rasmussen L.M., Ledet T. Diabetic macroangiopathy and atherosclerosis. Diabetes 1996, 45(Suppl. 3):S91-S94.
2. de La Motte C.A., Hascall V.C., Calabro A., et al. Mononuclear leukocytes preferentially bind via CD44 to hyaluronan on human intestinal mucosal smooth muscle cells after virus infection or treatment with poly(I.C). J. Biol. Chem. 1999, 274(43):30747-30755.
3. de La Motte C.A., Drazba J.A. Viewing hyaluronan: imaging contributes to imagining new roles for this amazing matrix polymer. J. Histochem. Cytochem. 2011, 59(3):252-257.
4. Lauer M.E., Aytekin M., Comhair S.A., et al. Modification of hyaluronan by heavy chains of inter-alpha-inhibitor in idiopathic pulmonary arterial hypertension. J. Biol. Chem. 2014, 289(10):6791-6798.
5. Swaidani S., Cheng G., Lauer M.E., et al. TSG-6 protein is crucial for the development of pulmonary hyaluronan deposition, eosinophilia, and airway hyperresponsiveness in a murine model of asthma. J. Biol. Chem. 2013, 288(1):412-422.
6. Sanggaard K.W., Sonne-Schmidt C.S., Jacobsen C., et al. Evidence for a two-step mechanism involved in the formation of covalent HC x TSG-6 complexes. Biochemistry 2006, 45(24):7661-7668.
7. Sanggaard K.W., Sonne-Schmidt C.S., Krogager T.P., et al. The transfer of heavy chains from bikunin proteins to hyaluronan requires both TSG-6 and HC2. J. Biol. Chem. 2008, 283(27):18530-18537.
8. Seyama Y., Wachi H. Atherosclerosis and matrix dystrophy. J. Atheroscler. Thromb. 2004, 11(5):236-245.
9. -/- mice. Arterioscler. Thromb. Vasc. Biol. 2006, 26(9):2117-2124.
10. Puato M., Rattazzi M., Zanon M., et al. Predictors of vascular remodelling in hypertensive subjects with well-controlled blood pressure levels. J. Hum. Hypertens. 2015, 29(9):561-565.
11. Johnson K.A., Polewski M., Terkeltaub R.A. Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells. Circ. Res. 2008, 102(5):529-537.
12. Speer M.Y., Chien Y.C., Quan M., et al. Smooth muscle cells deficient in osteopontin have enhanced susceptibility to calcification in vitro. Cardiovasc. Res. 2005, 66(2):324-333.
13. Venuraju S.M., Yerramasu A., Corder R., et al. Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity. J. Am. Coll. Cardiol. 2010, 55(19):2049-2061.
14. Chai S., Chai Q., Danielsen C.C., et al. Overexpression of hyaluronan in the tunica media promotes the development of atherosclerosis. Circ. Res. 2005, 96(5):583-591.
15. Lauer M.E., Fulop C., Mukhopadhyay D., et al. Airway smooth muscle cells synthesize hyaluronan cable structures independent of inter-alpha-inhibitor heavy chain attachment. J. Biol. Chem. 2009, 284(8):5313-5323.
16. de La Motte C.A., Hascall V.C., Drazba J., et al. Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid:polycytidylic acid: inter-alpha-trypsin inhibitor is crucial to structure and function. Am. J. Pathol. 2003, 163(1):121-133.
17. Lauer M.E., Glant T.T., Mikecz K., et al. Irreversible heavy chain transfer to hyaluronan oligosaccharides by tumor necrosis factor-stimulated gene-6. J. Biol. Chem. 2013, 288(1):205-214.
18. Lauer M.E., Cheng G., Swaidani S., et al. Tumor necrosis factor-stimulated gene-6 (TSG-6) amplifies hyaluronan synthesis by airway smooth muscle cells. J. Biol. Chem. 2013, 288(1):423-431.
19. Lauer M.E., Mukhopadhyay D., Fulop C., et al. Primary murine airway smooth muscle cells exposed to poly(I,C) or tunicamycin synthesize a leukocyte-adhesive hyaluronan matrix. J. Biol. Chem. 2009, 284(8):5299-5312.
20. Zhao M., Yoneda M., Ohashi Y., et al. Evidence for the covalent binding of SHAP, heavy chains of inter-alpha-trypsin inhibitor, to hyaluronan. J. Biol. Chem. 1995, 270(44):26657-26663.
21. Williams K.J., Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 1995, 15(5):551-561.
22. Greenwald S.E. Ageing of the conduit arteries. J. Pathol. 2007, 211(2):157-172.
23. Xu J., Shi G.P. Vascular wall extracellular matrix proteins and vascular diseases. Biochim. Biophys. Acta 2014, 1842(11):2106-2119.
24. Zarkovic K., Larroque-Cardoso P., Pucelle M., et al. Elastin aging and lipid oxidation products in human aorta. Redox. Biol. 2014, 4C:109-117.
25. Rensen S., Doevendans P., van E.G. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth. Heart J. 2007, 15(3):100-108.
26. Evanko S.P., Angello J.C., Wight T.N. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 1999, 19(4):1004-1013.
27. Heegaard A.M., Corsi A., Danielsen C.C., et al. Biglycan deficiency causes spontaneous aortic dissection and rupture in mice. Circulation 2007, 115(21):2731-2738.
28. Chaabane C., Coen M., Bochaton-Piallat M.L. Smooth muscle cell phenotypic switch: implications for foam cell formation. Curr. Opin. Lipidol. 2014, 25(5):374-379.